A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Launched by HOFFMANN-LA ROCHE · May 25, 2010
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients \>=18 years of age;
- • colon or rectal cancer, with metastases;
- • \>=1 measurable lesion.
- Exclusion Criteria:
- • previous systemic treatment for advanced disease;
- • radiotherapy to any site within 4 weeks before study;
- • daily aspirin (\>325 mg/day), anticoagulants, or other medications known to predispose to gastrointestinal ulceration;
- • co-existing malignancies or malignancies diagnosed within last 5 years (except basal cell cancer or cervical cancer in situ).
About Hoffmann La Roche
Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, Lazio, Italy
Bologna, Emilia Romagna, Italy
Udine, Friuli Venezia Giulia, Italy
Treviglio, Lombardia, Italy
Novara, Piemonte, Italy
Pavia, Lombardia, Italy
Palermo, Sicilia, Italy
Pisa, Toscana, Italy
Prato, Toscana, Italy
Carpi, Emilia Romagna, Italy
Cremona, Lombardia, Italy
Sondrio, Lombardia, Italy
Catania, Sicilia, Italy
Camposampiero, Veneto, Italy
Negrar, Veneto, Italy
Brescia, Lombardia, Italy
Firenze, Toscana, Italy
Varese, Lombardia, Italy
Grosseto, Toscana, Italy
Ancona, Marche, Italy
Mantova, Lombardia, Italy
Piacenza, Emilia Romagna, Italy
Benevento, Campania, Italy
Milano, Lombardia, Italy
Saronno, Lombardia, Italy
Napoli, Campania, Italy
Busto Arsizio, Lombardia, Italy
Lecco, Lombardia, Italy
Bolzano, Trentino Alto Adige, Italy
Paola, Calabria, Italy
Latisana, Friuli Venezia Giulia, Italy
Latina, Lazio, Italy
Casalpusterlengo, Lombardia, Italy
Gorgonzola, Lombardia, Italy
Legnago, Lombardia, Italy
Torino, Piemonte, Italy
Cagliari, Sardegna, Italy
Terni, Umbria, Italy
Este, Veneto, Italy
Montecchio Maggiore, Veneto, Italy
Patients applied
Trial Officials
Clinical Trials
Study Chair
Hoffmann-La Roche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials